Researchers from Rutgers University have found that most persons with multiple sclerosis (MS) opt for oral drugs to manage their chronic and worsening neurological conditions.
New Delhi, Nov.14 (ANI): A study on nation-wide trends in the sales of anti-diabetic oral drugs and insulins has found that there is a substantial rise in cost of treating diabetes in India.